Drug Type Tregs cell therapy |
Synonyms- |
Target |
Action modulators |
Mechanism NCOA3 modulators(nuclear receptor coactivator 3 modulators), Epigenetic drug |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Glioblastoma | Preclinical | United States | 24 Aug 2024 | |
| Lung Cancer | Preclinical | United States | 24 Aug 2024 | |
| Pancreatic Cancer | Preclinical | United States | 24 Aug 2024 | |
| Prostatic Cancer | Preclinical | United States | 24 Aug 2024 | |
| Triple Negative Breast Cancer | Preclinical | United States | 24 Aug 2024 |





